Exact Mass: 600.1115
Exact Mass Matches: 600.1115
Found 90 metabolites which its exact mass value is equals to given mass value 600.1115
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Kaempferol 7-(6'-galloylglucoside)
Kaempferol 7-(6-galloylglucoside) is isolated from Acacia farnesiana (sweet acacia). Isolated from Acacia farnesiana (sweet acacia)
2'-Galloylastragalin
2-galloylastragalin is a member of the class of compounds known as flavonoid-3-o-glycosides. Flavonoid-3-o-glycosides are phenolic compounds containing a flavonoid moiety which is O-glycosidically linked to carbohydrate moiety at the C3-position. 2-galloylastragalin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). 2-galloylastragalin can be found in japanese persimmon, which makes 2-galloylastragalin a potential biomarker for the consumption of this food product.
Kaempferol 3-(6-galloylgalactoside)
Kaempferol 3-(2-galloylglucoside)
Kaempferol 3-(6-galloylglucoside)
Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside is a glucopyranoside. Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside inhibts HIV-2 RNase H with an IC50 value of 5.19 μM[1].
Isoorientin 2'-O-gallate
(4S,5E,7Z,12R,14Z,17Z)-4-(alpha-D-glucopyranosyloxy)-17,18-didehydrobromovulone-3
4-O-(4-O-galloyl-alpha-L-rhamnopyranosyl)ellagic acid
Astragalin 6-gallate
Kaempferol 3-O-(6-galloyl)-beta-D-glucopyranoside is a natural product found in Eugenia hyemalis, Pemphis acidula, and other organisms with data available. Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside is a glucopyranoside. Kaempferol-3-O-(6′′-galloyl)-β-glucopyranoside inhibts HIV-2 RNase H with an IC50 value of 5.19 μM[1].
[(2S,3R,4R,5S,6S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl] 3,4,5-trihydroxybenzoate
[6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
[(2S,3R,4R,5R,6S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl] 3,4,5-trihydroxybenzoate
[(2S,3R,4R,5R,6S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-4,5-dihydroxy-6-methyloxan-3-yl] 3,4,5-trihydroxybenzoate
[(2S,3R,4R,5S,6S)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl] 3,4,5-trihydroxybenzoate
[6-[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate [IIN-based: Match]
2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-deoxy-3-O-(3,4,5-trihydroxybenzoyl)-?-L-mannopyranoside
Nicofuranose
C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AD - Nicotinic acid and derivatives C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98151 - Niacin-based Antilipidemic Agent C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
R-4-oxide-4-hydroxy-2,6-di-1-naphthalenyl-Dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
S-4-oxide-4-hydroxy-2,6-di-2-naphthalenyl-Dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin
Dinaphtho[2,1-d:1,2-f][1,3,2]dioxaphosphepin, 4-hydroxy-2,6-di-1-naphthalenyl-, 4-oxide, (11bS)
[6-[5,7-Dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
[(2r,3r,4s,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
(2s,3r,4s,5s,6r)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-6-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate
(2s,3r,4s,5s,6r)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl 3,4,5-trihydroxybenzoate
(2s,3r,4r,5r,6s)-2-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-3-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 3,4,5-trihydroxybenzoate
7,11-dibromo-12,15,22-trihydroxy-8,12,16,16-tetramethyl-4-methylidene-17-oxatricyclo[17.3.1.0³,⁸]tricosa-1(23),19,21-trien-18-one
[(2r,3r,4r,5r,6s)-6-{[5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxochromen-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl 3,4,5-trihydroxybenzoate
1ycorenium A
{"Ingredient_id": "HBIN003371","Ingredient_name": "1ycorenium A","Alias": "NA","Ingredient_formula": "C18H38I2N2O4","Ingredient_Smile": "C[N+](C)(C)CCOC(=O)CCCCCCC(=O)OCC[N+](C)(C)C.[I-].[I-]","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "39147","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3'-hydroxyscutellarein 7-o-(6''-o-protocatechuo-yl)-β-glucopyranoside
{"Ingredient_id": "HBIN008748","Ingredient_name": "3'-hydroxyscutellarein 7-o-(6''-o-protocatechuo-yl)-\u03b2-glucopyranoside","Alias": "NA","Ingredient_formula": "C28H24O15","Ingredient_Smile": "C1=CC(=C(C=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)COC(=O)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10694","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}